We decode LNPs, RNA, delivery tech, CAR-T, ADCs & personalized medicine through:

NanoSphere  nanomedicine update newsletter cover featuring lipid nanoparticle graphics and publication highlights

Monthly Newsletter

A monthly digest translating nanomedicine research, regulation, industry/business and clinical updates into clear, actionable insights. 

For whom: Academia, industry, and regulators. 

How it helps: 
  • Breaks silos by connecting sectors
  • Translates jargon into accessible language
  • Accelerates lab-to-market translation
  • Sparks collaboration through shared knowledge.
Curated by our team of experts.



NanoSphere monthly articles section showcasing nanomedicine insights with featured contributor portraits

Thought Leadership

A deep-dive into key nanomedicine topics—backed by real-time tools like our approved drug database and clinical pipeline tracker. 

For whom: Experts and decision-makers in biotech, and regulation. 

How it helps: 
  • Bridges sectors through shared, cross-functional knowledge
  • Gives visibility to global innovators with practical, forward-looking content
  • Enables action with live tools: approved drug database, modality trackers, and trial overviews.
Written by NanoSphere, reviewed by our collaborators.


NanoSphere weekly interview feature highlighting nanomedicine innovators, including researchers and industry leaders sharing insights and future directions

Weekly Interview Feature

A weekly feature highlighting diverse nanomedicine innovators—from rising researchers to industry leaders—sharing their vision, challenges, and next steps. 

For whom: Academia, industry, and regulatory professionals seeking inspiration and direction. 

How it helps: 
  • Amplifies voices often overlooked by top journals and platforms
  • Reveals real-world perspectives on the future of nanomedicine
  • Connects sectors through shared foresight and experience
  • Sparks collaboration by surfacing next-gen ideas and needs.  

 Check here for more.
NanoSphere daily academic digest featuring global research papers with expert commentary on clinical translation in nanomedicine

Daily Academic Digests

A daily series spotlighting global academic papers, enhanced with NanoSphere advice on clinical translation. 

For whom: Innovators across academia, biotech, and regulatory fields. 

How it helps: 
  • Elevates research beyond top journals
  • Translates scientific jargon into practical value
  • Connects sectors through expert context
  • Boosts visibility and cross-sector engagement
Curated by our experts for a clinical translation.

Thanks for the shout-out NanoSphere! I just learned about NanoSphere from this post, and now I see it is the place to go for all things nanomedicine. Super cool resource for the community! -Jake Brenner

Thank you to the NanoSphere team for the thoughtful interview and for providing the field with a hub of conversation that is difficult to find outside of conferences. A clear labor of love! - Sean Bedingfield

Enter Title Here

Excited to partner with NanoSphere, the premier global platform for nanomedicine innovation, to amplify our LNP expertise through targeted content sharing! - Rui Zhang

Enter Title Here

Also, congrats to the whole NanoSphere team for the great work you're doing and for the 360º vision you consistently provide on the state-of-the-art! - Alfonso F. Blanco

Enter Title Here

Nanosphere has been a valued partner for Latent Knowledge in helping us understand the unique needs of interdisciplinary scientists, allowing us to support their innovation efforts with literature search and knowledge management products. The Nanosphere team is knowledgeable, passionate, and open minded, everything you'd hope for in a startup partnership. Thank you Marija Petrovic and NanoSphere for your ongoing support! - James Reilly

Working with Marija was not only very efficient and effective but even fun! Marija made everything as easy as possible and was always available for questions or clarifications. I really enjoyed working with Marija and the Nanosphere team !! - John Rinn

Enter Title Here

We have been collaborating with NanoSphere and its team since the early stages of their journey, as their mission aligns perfectly with our own goal of making nanoparticle science and nanomedicine more accessible. Through their outstanding expertise in the nano space, strong connections within the field, and collaborative mindset, NanoSphere has become a valuable partner. We are extremely grateful for the work accomplished together and look forward to continuing this collaboration. -Robin Oliveres

Enter Title Here

Such a great platform you developed needs to get the biggest spotlight possible. -Philippe Tschopp

Enter Title Here

I have been following NanoSphere since the start. What drew me in was its fresh perspective, which makes complex scientific, business, and regulatory topics accessible while still offering in-depth resources for those who want to explore further. The rapidly expanding community confirms that this kind of space was needed, and conversations naturally unfold around important topics and a variety of voices. I can only suggest keeping up your excellent work!-Paola Luciani

Enter Title Here

I had an amazing collaboration with Marija and NanoSphere when we did an interview together on the topic of mRNA-LNP and vaccines. Their approach, organization, and communication and interview preparation were highly professional and knowledgeable. I would gladly work with the Nanosphere team again. they have succeeded to become SMEs in the field and I follow their regular updates to be informed on the state of art. - Eleni Samaridou

Enter Title Here

Communities like NanoSphere are essential because they connect dots that often remain isolated. What we need most is open knowledge about what didn’t work, the experiments, formulations, and models that failed but taught us something valuable. Sharing these experiences can save others years of effort and help the field mature faster. -Alvaro Somoza

Enter Title Here

NanoSphere can be the field’s everyday home base: you ask early, you get a clear next step, and you share what actually worked. -Eva Hemmrich

Enter Title Here

Marija guided me through an interview process & thoughtfully reminded me of deadlines. She was very flexible when I was running late delivering a questionnaire and was decisive in bringing it over the finish line. Based on this, I would always work with her again. -Philipp Beck

Enter Title Here

Communities like NanoSphere play a critical role in shaping the future of nanomedicine by acting as true communities of knowledge. They go beyond information sharing to create spaces where ideas, experiences, and challenges can be openly discussed, influencing how the field evolves and how innovation is translated into real impact.-María de la Fuente Freire

Enter Title Here

Collaborating with Marija has been a true pleasure. She possesses deep expertise in nanomedicine and drug delivery, and she conducts her work with the utmost professionalism and reliability. Marija consistently goes above and beyond, ensuring that tasks are completed not only to the highest standard but also with remarkable efficiency. Her dedication makes collaboration both productive and genuinely enjoyable. -Olivia Merkel

Enter Title Here

First of all, let me congratulate you for this great effort in the form of Nanosphere. I studied your website and learned about the AI tools which look very helpful. I am sharing it with my students and colleagues. Nanosphere is playing a crucial role in influencing the public opinion which will be helpful in adoption of nanomedicine approaches in cancer clinics. Even we as scientists should take it as a first level of reading before diving deep into specific papers and data. -Mohammad Azhar Aziz

Enter Title Here

Marija brings together a solid scientific background and a mature business acumen. We have collaborated on several projects and campaigns and I'm sure we will collaborate more in the future. -Omar Shoukry Sakr

Enter Title Here

Initiatives like NanoSphere are especially valuable because they connect researchers working at all stages of translation, from fundamental science to clinical application. This mission is reinforced by a growing ecosystem of scientific communities. -Giovanna Lollo

Enter Title Here

What I find most valuable about platforms like NanoSphere is that they create a shared space in a field that is still very fragmented. Nanomedicine brings together formulation science, clinical development, regulatory thinking, and increasingly data science, but these areas often evolve in parallel rather than together. Having a place where these perspectives are translated and connected is already a meaningful contribution.-Carlos Victor Montefusco Pereira

Enter Title Here

Communities like NanoSphere play an important role because they create space for conversations that don’t easily fit into papers, grant proposals, or press releases. A lot of what actually matters in this field: why things failed, where assumptions turned out to be wrong, what took far longer than expected, rarely makes it into the formal record. Having platforms that allow those experiences to be shared openly is extremely valuable.-Raymond Schiffelers

Enter Title Here

My project with Marija went very well: responsiveness, pro-activity, scientific knowledge. -Yvan Devaux

Enter Title Here

Communities like NanoSphere are vital in bridging the persistent gaps between discovery, translation, and clinical application in nanomedicine. By connecting interdisciplinary experts—from fundamental researchers to translational scientists and clinicians—you accelerate the entire field.-Zhenghong Gao

Enter Title Here

The propagation of scientific knowledge has never been more crucial. The vast array of information available digitally makes it essential to have trusted sources. NanoSphere not only brings reliable information to the nanomedicine field, it also does it in an innovative way, by putting thought leaders forward, thus promoting innovation in the field.-Dimitri Aubert

Enter Title Here

Platforms like NanoSphere play an important role in encouraging people to step outside their own laboratories and disciplinary silos. In a field as complex as nanomedicine, it is essential to see what others are doing, how they are thinking, and which challenges they are facing. Having a platform where ideas, experiences, and lessons learned can be openly exchanged creates a perspective that is difficult to gain when working in isolation.-Boris Sevarika

Enter Title Here

Communities like NanoSphere fill a gap that formal institutions don't reliably address: cross-disciplinary dialogue, in public, in an accessible manner. Nanomedicine sits at the intersection of biophysics, chemistry, biology, engineering, and clinical medicine—and those communities often talk past each other. A conference brings people together for three days; a platform like NanoSphere can sustain a conversation across months and years.-Gaurav Goyal

Enter Title Here

NanoSphere is a very useful platform because it provides an interesting update of very specific knowledge. I am following your newsletters, interviews, and thought leadership; it is very enriching and inspiring content. -Khair Alhareth

Enter Title Here

Platforms like NanoSphere play an important role in a field that is still quite fragmented across science, industry, and clinical application. What makes the platform particularly valuable is its ability to bring these different perspectives together, from cutting-edge research to regulatory and business developments.-Jan Brummund

Enter Title Here

Conversations now stretch across continents, often in real time, through platforms we didn’t take seriously a decade ago. That’s where communities like NanoSphere come in. Not as another channel to broadcast results, but as a space to connect people. Students, postdocs, and professors who are all trying to make sense of the same questions from different angles. Because science isn’t abstract. It’s not papers or impact factors. It’s people. And progress happens when those people actually talk to each other.-Matthias Wacker

Enter Title Here

Marija has excellent scientific communication skills. It was a great pleasure to work with her! -Oya Tagit

Enter Title Here

Communities like NanoSphere play an important role in bringing together the different parts of the nanomedicine ecosystem e.g., scientists, technology developers, drug developers, manufacturers, and regulators. The field of nanomedicine is evolving very quickly, and progress depends on meaningful dialogue across all of these groups.-Padma Kodukula

Enter Title Here

I really applaud platforms like NanoSphere. In such a rapidly progressing field, providing a forum for innovative ideas to be shared with the community is crucial to advancing the development of RNA therapeutics-Brendan Darby

Enter Title Here

Communities like NanoSphere are essential for building the bridges between fundamental science and real-world applications. Where NanoSphere and similar platforms add immense value is connecting science with industry - deep-tech startups often struggle to find the right partners, and platforms that facilitate connections between innovators, manufacturers, investors, and regulators accelerate the path to market.-Olga Fontanellaz

Follow us 

Our audience is facing three main problems:

  • Lack of Visibility 
    Innovative research and emerging voices often go unnoticed—especially outside top-tier journals or major institutions.
  • Fragmented Communication
    Limited collaboration between academia, industry, clinicians and regulators slows translation and real-world application.
  • Overwhelming Complexity
    Regulatory jargon, clinical trial data, and scientific literature are hard to navigate, especially without access to a live, structured nanomedicine market database.
NanoSphere audience distribution by region – Europe 58%, North America 26%, Asia 10%, other regions 6%
NanoSphere audience by industry – Biotechnology research 28%, Higher education 23%, Pharmaceutical manufacturing 18%, Research services 17%, other sectors 14%
NanoSphere monthly nanomedicine newsletter preview – join 2,800+ experts for curated insights bridging research, regulation, and real-world application
subscribe to our newsletter by clicking on the video

Join 5,500+ experts receiving clear, curated insights bridging research, regulation, and real-world application—delivered monthly.

NanoSphere doesn’t just report nanomedicine developments, it translates them.

What does each get out of NanoSphere?

Academics  Visibility + Industry Context
Industry  Tech scouting + BD leads
Regulators  Early risk signals across platforms
Clinicians  Signals from preclinical/clinical studies
Investors  Emerging trends platform potential

Just make sure to follow us here.

Followers

NanoSphere has reached 5,000 LinkedIn followers on Linkedin, a 260% increase since July 2024.

Monthly Website Visits 

10 000 monthly visits to site have grown by around 338% since our newsletter in October 2024.

Global hub

From Boston to Basel, NanoSphere is driving the nanomedicine conversation in 40+ global centers.
Video preview of NanoSphere Nanomedicine Guide GPT explaining the role of lipid nanoparticle size in drug delivery and immune system evasion

Nanomedicine guide GPT

This GPT is a nanomedicine and nanotechnology assistant powered by a specialized database, designed to help you with lipid nanoparticles (LNPs), polymer-based drug delivery systems, and nucleic acids such as mRNA, DNA, and RNA therapeutics.
Video preview of NanoSphere N/P ratio calculator GPT showing step-by-step guide for calculating nitrogen-to-phosphorus ratios in nanomedicine formulations

N/P ratio calculator GPT

This prompt is backed by scientific references to assist you in calculating N/P ratios, molecular weights, and the required mass of the substance for your formulation.
Make Nanomedicine Clear, Connected, and Clinical
Every article, interview, and tool helps nanomedicine translate faster, smarter, and more collaboratively.
NanoSphere envisions to own the global conversation around nanomedicine.

What sets us apart?


NanoSphere competitive comparison chart highlighting differences from three competitors, showing focus on nanomedicine, expert-curated fast content, original research, and collaboration with academia and industry


Words from our stakeholders



”Thanks for the shout-out NanoSphere! I just learned about NanoSphere from this post, and now I see 𝗶𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗽𝗹𝗮𝗰𝗲 𝘁𝗼 𝗴𝗼 𝗳𝗼𝗿 𝗮𝗹𝗹 𝘁𝗵𝗶𝗻𝗴𝘀 𝗻𝗮𝗻𝗼𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲. Super cool resource for the community!”

Testimonial from Jake Brenner, Assistant Professor at the University of Pennsylvania, praising NanoSphere as the place to go for all things nanomedicine
About
Jake Brenner
Assistant Professor at the University of Pennsylvania

- NanoSphere curated academic post

„Thank you to the NanoSphere team for the thoughtful interview and for providing the field with a hub of conversation that is difficult to find outside of conferences. A clear labor of love!”
Testimonial from Sean Bedingfield, PhD, Senior Advisor at Eli Lilly and Company's Genetic Medicine division, praising NanoSphere for providing a unique hub of conversation outside conferences
About
Sean Bedingfield PhD, Senior Advisor at Eli Lilly and Company's Genetic Medicine division

- NanoSphere interview

„Excited to partner with NanoSphere, the premier global platform for nanomedicine innovation, to amplify our LNP expertise through targeted content sharing!”

Partnership announcement from XGen Bio highlighting NanoSphere as the premier global platform for nanomedicine innovation and LNP expertise sharing
About
XGen Bio




- NanoSphere collaboration

A Clearer, Faster Future for Nanomedicine

NanoSphere envisions a world where life-changing nanomedicine innovations are no longer buried in silos or slowed by complexity. By translating knowledge into impact, NanoSphere accelerates the journey from bench to bedside—so that scientific breakthroughs reach patients faster, smarter, and with greater global reach.
Close-up multicolored eye graphic symbolizing NanoSphere’s vision for connecting researchers, industry, and regulators in nanomedicine

We are building a future where:

Researchers gain visibility beyond academic journals.

Industry, regulators, clinicians and academia collaborate seamlessly.

Every insight is accessible, actionable, and aligned with real-world needs.
Search